Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

NCT03399552 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Malignant Mesothelioma (MPM)

Interventions

DRUG: Avelumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]